ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $99,000 | -29.3% | 48,618 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $140,000 | +351.6% | 48,618 | +1114.8% | 0.00% | – |
| Q2 2019 | $31,000 | -97.7% | 4,002 | -93.7% | 0.00% | -100.0% |
| Q4 2017 | $1,373,000 | -9.3% | 64,007 | 0.0% | 0.01% | -14.3% |
| Q3 2017 | $1,514,000 | +253.7% | 64,007 | +194.3% | 0.01% | +250.0% |
| Q2 2017 | $428,000 | -40.2% | 21,751 | -36.2% | 0.00% | -33.3% |
| Q1 2017 | $716,000 | – | 34,116 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |